α-Catulin downregulates E-cadherin and promotes melanoma progression and invasion

International Journal of Cancer

Volumn 132, Issue 3, 2013, Pages 521-530

  Kreiseder, Birgit ^a   Orel, Lukas ^b   Bujnow, Constantin ^a   Buschek, Stefan ^a   Pflueger, Maren ^a   Schuett, Wolfgang ^a   Hundsberger, Harald ^a   De Martin, Rainer ^b   Wiesner, Christoph ^a  

^a IMC UNIVERSITY OF APPLIED SCIENCES KREMS   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

catulin; invasion; melanoma progression

Indexed keywords

ALPHA CATULIN; BINDING PROTEIN; GELATINASE A; GELATINASE B; NERVE CELL ADHESION MOLECULE; RHO FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SPHEROID; UPREGULATION;

ALPHA CATENIN; BETA CATENIN; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; EPIDERMIS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOCYTES; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; RHO-ASSOCIATED KINASES; SPHEROIDS, CELLULAR; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84870250642     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27698     Document Type: Article

References (40)

1. Clark WH, Elder DE, Guerry D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893-1904.
2. Howard K, Koh HK,. Cutaneous melanoma. N Engl J Med 1991; 325: 171-82.
3. Mooi WJ,. Diagnosis of thin melanoma. J Clin Pathol 1997; 50: 179-80.
4. Haass NK, Herlyn M,. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 2005; 10: 153-63.
5. Clark WH, Jr,. Human cutaneous malignant melanoma as a model for cancer. Cancer Metastasis Rev 1991; 10: 83-8.
6. Sondak VK, Ross MI, Schuchter LM,. Early stage (I, II, III) melanoma. Curr Treat Options Oncol 2001; 2: 183-91; Review.
7. Tang A, Eller MS, Hara M, et al. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994; 107 (Part 4): 983-92.
8. Hsu MY, Wheelock MJ, Johnson KR, et al. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc 1996; 1: 188-94.
9. Nagafuchi A,. Molecular architecture of adherens junctions. Curr Opin Cell Biol 2001; 13: 600-3; Review.
10. Poser I, Domínguez D, de Herreros AG, et al. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001; 276: 24661-6.
11. Li G, Satyamoorthy K, Meier F, et al. Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 2003; 22: 3162-71.
12. Hsu MY, Meier FE, Nesbit M, et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000; 156: 1515-25.
13. Thiery JP,. Epithelial-mesenchymal transitions in cancer onset and progression. Bull Acad Natl Med 2009; 193: 1969-78; discussion 1978-9.
14. Thiery JP,. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54.
15. Huber MA, Kraut N, Beug H,. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-58.
16. De Craene B, Gilbert B, Stove C, et al. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 2005; 65: 6237-44.
17. Peinado H, Olmeda D, Cano A,. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-28.
18. Houghton AN, Polsky D,. Focus on melanoma. Cancer Cell 2002; 2: 275-8.
19. Amiri KI, Richmond A,. Role of nuclear factor-κB in melanoma. Cancer Metastasis Rev 2005; 24: 301-13.
20. Huang S, Pettaway CA, Uehara H, et al. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001; 20: 4188-97.
21. Gupta GP, Minn AJ, Kang Y, et al. Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 2005; 70: 149-58.
22. Payne AS, Cornelius LA,. The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 2002; 118: 915-22.
23. Ip YT, Park RE, Kosman D, et al. Dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev 1992; 6: 1518-30.
24. Barberà MJ, Puig I, Domínguez D, et al. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 2004; 23: 7345-54.
25. Wiesner C, Winsauer G, Resch U, et al. α-Catulin, a Rho signalling component, can regulate NF-κB through binding to IKK-β, and confers resistance to apoptosis. Oncogene 2008; 27: 2159-69.
26. Park B, Nguyen NT, Dutt P, et al. Association of Lbc Rho guanine nucleotide exchange factor with α-catenin-related protein, α-catulin/CTNNAL1, supports serum response factor activation. J Biol Chem 2002; 277: 45361-70.
27. Merdek KD, Nguyen NT, Toksoz D,. Distinct activities of the α-catenin family, α-catulin and α-catenin, on β-catenin-mediated signaling. Mol Cell Biol 2004; 24: 2410-22.
28. Amatschek S, Lucas R, Eger A, et al. CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. Br J Cancer 2011; 104: 469-79.
29. Swoboda A, Rasin-Streden D, Schanab O, et al. Identification of genetic disparity between primary and metastatic melanoma in human patients. Genes Chromosomes Cancer 2011; 50: 680-8.
30. Behrens J, Lowrick O, Klein-Hitpass L, et al. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 1991; 88: 11495-9.
31. Wegener WA, Petrelli N, Serafini A, et al. Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration. J Nucl Med 2000; 41: 1016-20.
32. Wiesner C, Pflüger M, Kopecky J, et al. Implementation of ECIS technology for the characterization of potential therapeutic drugs that promote wound-healing. GMS Krankenhhyg Interdiszip 2008; 3: Doc05.
33. Fan LC, Chiang WF, Liang CH, et al. α-Catulin knockdown induces senescence in cancer cells. Oncogene 2011; 30: 2610-21.
34. Kim HS, Lee YH, Lee YR, et al. Activation of professional antigen presenting cells by acharan sulfate isolated from giant African snail, Achatina fulica. Arch Pharm Res 2007; 30: 866-70.
35. Bates RC, Edwards NS, Yates JD,. Spheroids and cell survival. Crit Rev Oncol Hematol 2000; 36: 61-74.
36. Redondo P, Lloret P, Idoate M, et al. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression. Clin Exp Dermatol 2005; 30: 541-5.
37. Hofmann U, Westphal J, van Muijen G, et al. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115: 625-32.
38. Lu Z, Ghosh S, Wang Z, et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell 2003; 4: 499-515.
39. Kuphal S, Poser I, Jobin C, et al. Loss of E-cadherin leads to upregulation of NFκB activity in malignant melanoma. Oncogene 2004; 23: 8509-19.
40. Guilford P,. E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 1999; 5: 172-7.